|
Wednesday, October 6, 2004
|
| 08:00 - 09:00 |
Meet the Expert III |
|
| Meeting 1: |
PSYCHOSEXUAL PROBLEMS
Chairpersons:
A. P. Heintz, Utrecht, The Netherlands
S. Carr, Glasgow, UK |
Hall B |
| 08:00 |
INTRODUCTION
A. P. Heintz, Utrecht, The Netherlands |
| 08:15 |
APPROACHES TO TREATMENT
S. Carr, Glasgow, UK |
| Meeting 2: |
INTRA PERITONEAL CHEMOTHERAPY
Chairperson:
D.S. Alberts, Tucson AZ, USA
K. Fujiwara, Kurashiki-City, Japan |
Hall D |
| 08:00 |
GOG AND SWOG IP STUDIES
D.S. Alberts, Tucson AZ, USA |
| 08:10 |
AN UPDATE OF GOG-172
D. Armstrong, Baltimore, MD, USA |
| 08:20 |
IP CARBOPLATIN BASED CHEMOTHERAPY FOR
OVARIAN CANCER
K. Fujiwara, Kurashiki City, Japan |
| 08:30 |
Panel Discussion
WHAT ARE THE NEXT STEPS FOR IP CHEMOTHERAPY? |
| Meeting 3: |
THE DO IT YOURSELF GUIDE TO DESIGNING AND RUNNING THERAPEUTIC
TRIALS
Chairpersons:
E.A. Eisenhauer, Kingston ON, Canada
M. Parmar, London, UK
|
Hall E |
| 08.00 |
PHASE I/II TRIALS - WHEN AND HOW?
E.A. Eisenhauer, Kingston ON, Canada
|
| 08:15 |
PHASE III TRIALS IN FRONT LINE: WHAT QUESTIONS ARE
INTERESTING? WHAT POPULATIONS SHOULD BE STUDIED? WHAT
ENDPOINTS AND DESIGN?
M. Brady, Buffalo, NY, USA |
| 08:30 |
PHASE III TRIAL DESIGN IN SECOND LINE: WHAT QUESTIONS
AND DESIGNS? HOW TO TALK TO STATISTICIANS EFFECTIVELY
M. Parmar, London, UK |
| 08:45 |
Discussion with "case" examples |
| Meeting 4: |
LAPAROSCOPIC SURGERY
Chairperson:
D. Querleu, Toulouse, France
I.G. Hammond, Perth, Australia |
Hall A |
| 08:00 |
ENDOMETRIAL CANCER
I.G. Hammond, Perth WA, Australia |
| 08:15 |
STAGING OF CERVICAL CANCER
D. Querleu, Toulouse, France |
| 08.30 |
SURGERY FOR CERVICAL CANCER
M.L Roy, Quebec QC, Canada |
| 08:45 |
STAGING OF OVARIAN CANCER
E. Leblanc, Lille, France |
| Meeting 5: |
VIN & VAIN
Chairperson:
D.M. Luesley, Birmingham, UK |
Hall C |
| 08.00 |
VACCINE APPROACHES TO MANAGEMENT
H.C. Kitchener, Manchester, UK |
| 08.15 |
CURRENT MANAGEMENT OF VAIN
Q. Davies, Leicester, UK |
| 08.30 |
THE MEDICAL MANAGEMENT OF VIN
R. Todd, Birmingham, UK |
| 08.45 |
SURGICAL APPROACHES TO MANAGEMENT OF VIN
D. Luesley, Birmingham, UK |
| Meeting 6: |
NOVEL CONCEPTS IN RADICAL SURGERY
Chairpersons:
M. Höckel, Leipzig, Germany
N. Sakuragi, Sapporo, Japan |
Hall F |
| 08:00 |
A SYSTEMATIC NERVE-SPARING RADICAL HYSTERECTOMY AND
POST-OPERATIVE BLADDER FUNCTION ASSESSED BY URODYNAMIC
STUDY
N. Sakuragi, Sapporo, Japan |
| 08:30 |
TOTAL MESOMETRIAL RESECTION (TMMR): NERVE- SPARING
RADICAL HYSTERECTOMY
A NEW DEFINITION OF SURGICAL RADICALITY BASED ON EMBRYOLOGICAL/FETAL
DEVELOPMENT
TMMR AS INTEGRAL PART OF A TREATMENT STRATEGY FOR CERVICAL
CARCINOMA
FIGO STAGES IB-IIB USING SURGERY ONLY AS LOCAL THERAPY
M. Höckel, Leipzig, Germany |
| 09:00-10:30 |
State of the Art Session
II, III |
|
| II. |
CERVICAL CANCER
Chairpersons:
E. Trimble, Bethesda MD, USA
S. Khleif, Bethesda, MD, USA |
Hall A |
| 09:00 |
DEVELOPMENTS IN SCREENING
J. Cuzick, London, UK |
|
| 09:15 |
RNA INTERFERENCE
J. Milner,York, UK
|
|
| 09:30 |
DECISION MAKING IN SURGERY
B.E. Greer, Seattle WA, USA
|
|
| 09:45 |
SYSTEMIC THERAPY
D.H. Moore, Indianapolis IN, USA |
|
| 10:00 |
ACUTE AND LATE TOXICITY OF THERAPY
J.M.Kirwan, Liverpool, UK |
|
| 10:15 |
PALLIATION
J.N. Lickiss, Sydney, NSW, Australia |
|
| III. |
ENDOMETRIAL CANCER
Chairpersons:
M. Quinn, Melbourne VIC, Australia
K.C. Podratz, Rochester MN, USA |
Hall G |
| 09:00 |
HIGH RISK INDIVIDUALS
K.H. Lu, Houston TX, USA |
|
| 09:15 |
SURGERY
J.G. Aalders, Groningen,The Netherlands |
|
| 09:30 |
RADIOTHERAPY
I. Ackerman, Toronto ON, Canada |
|
| 09:45 |
PROGNOSTIC PREDICTORS
C. L. Creutzberg, Rotterdam, The Netherlands |
|
| 10:00 |
MANAGEMENT OF RECURRENCE
A.M. Oza, Toronto ON, Canada |
|
| 10:15 |
Discussion |
|
| 11:00 - 12:30 |
Satellite Symposium III |
Hall A |
| |
| Sponsored by Eli Lilly |
 |
| |
|
|
| |
MANAGEMENT OF RECURRENT OVARIAN CANCER
Chairpersons:
J. Pfisterer, Kiel, Germany
I. Vergote, Leuven, Belgium |
| 11:00 |
WELCOME AND OVERVIEW OF EDUCATIONAL OBJECTIVES
J. Pfisterer, Kiel, Germany
I. Vergote, Leuven, Belgium |
| 11:05 |
TREATMENT GOALS AND CLINICAL TRIAL DESIGN IN RECURRENT
OVARIAN CANCER
S.B. Kaye, Sutton, UK |
| 11:25 |
DEBATE #1: MONOTHERAPY VS COMBINATION THERAPY IN THE
TREATMENT OF PLATINUM RESISTANT OVARIAN CANCER
P. Rose, Cleveland OH, USA
I. Vergote, Leuven, Belgium |
| 11:55 |
DEBATE #2: MONOTHERAPY VS COMBINATION THERAPY IN THE
TREATMENT OF PLATINUM SENSITIVE OVARIAN CANCER
P. Harper, London, UK
A. du Bois, Wiesbaden, Germany |
| 12:25 |
Q&A, Closing remarks
J. Pfisterer, Kiel, Germany
I. Vergote, Leuven, Belgium |
| 12:30 - 13:30 |
Frontier Session |
Hall I |
| |
Frontiers J:
POTENTIAL OF CHEMOPREVENTION
Chairpersons: P. Boyle, Lyon, France
R. Leake, Glasgow, UK
|
|
| 12:20 |
CURRENT USE AND FUTURE POTENTIAL FOR TAMOXIFEN
P. Boyle, Lyon, France |
|
| 12:40 |
CHEMOPREVENTION OF BREAST CANCER
J. Cuzick, London, UK |
|
| 13:00 |
CHEMOPREVENTION OF CERVICAL NEOPLASIA USING DIINDOLYLMETHANE
(DIM): THE DESIGN AND RATIONALE OF CRISP
P. Sasieni, London, UK
|
|
| 13:30 - 15:00 |
Free Communications Session
|
Hall A |
| |
Plenary Session |
|
Chairpersons:
A. Poveda Velasco, Valencia, Spain
J-H. Hong, Taoyuan, Taiwan
|
| 15:00 - 16:30 |
Specialist Group Meetings
- Nurses |
Hall A |
| |
Chairpersons:
R. McCahill, Glasgow, UK
K. Nattress, Sydney, Australia |
|
| |
AN INVESTIGATION INTO THE ATTITUDES, BELIEFS AND BEHAVIOUR
OF GYNAECOLOGICAL NURSES REGARDING THE MANAGEMENT OF RADICAL
VULVECTOMY WOUNDS
C.M. Hughes, London, UK |
|
| |
WHAT ARE THE INFORMATION NEEDS REGARDING MENOPAUSE
AND HORMONE REPLACEMENT THERAPY (HRT) FOR WOMEN WITH GYNAECOLOGICAL
CANCER?
H. Pratt, London, UK |
|
| |
THE EXPERIENCES OF WOMEN AFTER A WIDE LOCAL EXCISION
FOR VULVAL CANCER
E. Toms, London, UK
|
|
| 15:30 - 17:00 |
Frontiers Sessions |
|
| G. |
SURGERY FOR CERVICAL CANCER - HOW CONSERVATIVE
CAN WE BE?
Chairperson:
A. Covens, Toronto ON, Canada |
Hall B |
| 15:30 |
CONE BIOPSY ALONE FOR EARLY STAGE CARCINOMA OF THE
CERVIX
M. Quinn, Melbourne VC, Australia |
|
| 16:00 |
HOW SAFE IS RADICAL TRACHELECTOMY
M.L. Roy, Quebec City, QC, Canada |
|
| 16:30 |
HOW MUCH OF THE PARAMETRIUM DO WE NEED TO RESECT?
F. Landoni, Milan, Italy |
|
| H. |
ADVANCES IN MOLECULAR PATHOLOGY
Chairperson:
M. Wells, Sheffield, UK |
Hall G |
| 15.30 |
HUMAN PAPILLOMAVIRUSES - NEW APPROACHES IN THE STUDY
OF LOWER FEMALE GENITAL TRACT NEOPLASIA
J. O'Leary, Dublin, Ireland |
|
| 16.00 |
THE MOLECULAR PATHOLOGY OF ENDOMETRIAL CARCINOMA
J. Prat, Barcelona, Spain |
|
| 16.30 |
THE MOLECULAR PATHOLOGY OF OVARIAN EPITHELIAL NEOPLASIA
A. Ayhan, Hamamatsu, Japan |
|
| I. |
MODELS OF GYNAECOLOGICAL CANCER
Chairperson:
T.C. Hamilton, Philadelphia PA, USA
|
Hall H |
| 15:30 |
MODELING OVARIAN CANCER IN THE MOUSE
D. Connolly, Philadelphia PA, USA |
| 16:00 |
GENE EXPRESSION ALTERATIONS IN OVARIAN
TUMORS FROM TRANSGENIC MICE
M. Birrer, Rockville MD, USA |
| 16:30 |
Discussion |
K. 
|
SENTINEL NODES IN STAGING GYNAECOLOGICAL CANCER
Chairperson:
A.J.G. van der Zee, Groningen, The Netherlands
In this session a distinguished faculty will answer
the following questions on SLN detection in the respective
gynecologic tumors; what is the rationale, current evidence
for its clinical implementation and what further information
do we need? |
Hall C |
| 15:30 |
SENTINEL NODE DETECTION IN BREAST CANCER
F. Amant, Leuven, Belgium |
| 15:45 |
SENTINEL NODE DETECTION IN ENDOMETRIAL CANCER
C.L. Levenback, Houston TX, USA |
| 16:00 |
SENTINEL NODE DETECTION IN CERVICAL CANCER
L. Rob, Prague, Czech Republic
|
|
| 16:15 |
SENTINEL NODE DETECTION IN VULVAR CANCER
A.G.J. van der Zee, Groningen, The Netherlands
|
|
| 16:30 |
GROIN ULTRASOUND AND FINE NEEDLE ASPIRATION IN VULVAL
CANCER: IN PLACE OF OR IN ADDITION TO SENTINEL NODE DETECTION
D. Barton, London, UK |
|
| 16:45 |
RESULTS OF THE ALMANAC TRIAL
R. Mansel, Cardiff, UK |
|
| 17:00 |
Discussion |
|
| Top |
|
